Investors. ImmuCell Corporation (Nasdaq: ICCC) has developed the First Defense® product line to deliver Immediate Immunity™ against E. coli, coronavirus, ...
Annual Report and Proxy. CORPORATE GOVERNANCE. ICCC Code of Conduct · Charter ... INVESTOR CONTACT. Lytham Partners, LLC iccc@lythampartners.com 602.889.9700 ...
Find the latest ImmuCell Corporation (ICCC) stock quote, history, news and other vital information to help you with your stock trading and investing.
Missing: investor relations
The Investor Relations website contains information about Illinois Casualty Co's business for stockholders, potential investors, and financial analysts.
Missing: iccc | Show results with:iccc
Find annual and quearterly earnings data for ImmuCell Corporation Common Stock (ICCC) including earnings per share, earnings forecasts at Nasdaq.com.
At IFC, our investments aim to create positive impacts alongside financial returns. Our robust ESG framework and Performance Standards have earned us a triple-A ...
Missing: iccc | Show results with:iccc
People also search for
View Insider related Regulatory Filings: Forms 3, 4 & 5. View Document Grouping descriptions. Search SEC Filings. Document Group ...
... (ICCC) CEO Michael Brigham on Q4 2019 Results - Earnings Call Transcript · SA TranscriptsWed, Feb. 19, 2020. ImmuCell (ICCC) Investor Presentation - Slideshow.
Missing: relations | Show results with:relations
This information can be used by investors to verify and understand the financial position of the company. Many, but not all SEC filings are available in the ...
Investor Relations. SAIC 2024 INVESTOR DAY. Presentation · Webcast. Investor Menu ... Vice President, Investor Relations 703-488-8528 investorrelations@saic.com ...